Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3 ‐ITD positive AML
European Journal of Haematology · 2023
DOI: 10.1111/ejh.14055 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Haematology, 2023. Verfasst von Toru Miyajima und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Graduate School of Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objectives
The cryptic fusion oncogene NUP98::NSD1 is known to be associated with FLT3 ‐ITD mutation in acute myeloid leukemia (AML), and an independent poor prognostic factor in pediatric AML. However, there are little data regarding the clinical significance of NUP98::NSD1 in adult cohort.
Methods
We conducted a multicenter retrospective study to investigate the prevalence, clinical characteristics, and prognostic impact of NUP98::NSD1 in adult FLT3 ‐ITD‐positive AML patients.
Results
In a total of 97 FLT3 ‐ITD‐positive AML patients, six cases (6.2%) were found to harbor the NUP98::NSD1 fusion transcript. NUP98::NSD1 positive cases had significantly higher platelet counts and a higher frequency of FAB‐M4 morphology than NUP98::NSD1 negative cases. NUP98::NSD1 was found to be mutually exclusive with NPM1 mutation, and was accompanied by the WT1 mutation in three of the six cases. The presence of NUP98::NSD1 fusion at the time of diagnosis predicted poor response to cytarabine‐anthracycline‐based intensive induction chemotherapy (induction failure rate: 83% vs. 36%, p = .038). Five of the six cases with NUP98::NSD1 underwent allogeneic hematopoietic stem cell transplantation (HSCT). Two of the five cases have successfully maintained remission, with one of them being rescued through a second HSCT.
Conclusions
Detecting NUP98::NSD1 in adult FLT3 ‐ITD‐positive AML is crucial to recognizing chemotherapy‐resistant group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Graduate School of Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.
- Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
- Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
- Blood Disorders Center, Aiiku Hospital, Sapporo, Japan.
- Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan.
- Department of Hematology, Kushiro Rosai Hospital, Kushiro, Japan.
ORCID-Profile: Toru Miyajima, Masahiro Onozawa, Toshihiro Matsukawa, Hideki Goto, Junichi Sugita, Daisuke Hidaka, Reiki Ogasawara, Akio Mori, Akio Shigematsu, Takeshi Kondo, Takanori Teshima
Zitieren
APA
Miyajima, T., Onozawa, M., Yoshida, S., Miyashita, N., Kimura, H., Takahashi, S., Yokoyama, S., Matsukawa, T., Goto, H., Sugita, J., Fujisawa, S., Hidaka, D., Ogasawara, R., Mori, A., Matsuoka, S., Shigematsu, A., Wakasa, K., Kasahara, I., Saga, T., …, & Teshima, T. (2023). Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3 ‐ITD positive AML. European Journal of Haematology. https://doi.org/10.1111/ejh.14055
Vancouver
Miyajima T, Onozawa M, Yoshida S, Miyashita N, Kimura H, Takahashi S, et al. Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3 ‐ITD positive AML. European Journal of Haematology. 2023. doi:10.1111/ejh.14055
BibTeX
@article{Miyajima2023,
author = {Miyajima, Toru and Onozawa, Masahiro and Yoshida, Shota and Miyashita, Naoki and Kimura, Hiroyuki and Takahashi, Shogo and Yokoyama, Shota and Matsukawa, Toshihiro and Goto, Hideki and Sugita, Junichi and Fujisawa, Shinichi and Hidaka, Daisuke and Ogasawara, Reiki and Mori, Akio and Matsuoka, Satomi and Shigematsu, Akio and Wakasa, Kentaro and Kasahara, Ikumi and Saga, Tomoyuki and Hashiguchi, Junichi and Takeda, Yukari and Ibata, Makoto and Yutaka, Tsutsumi and Fujimoto, Katsuya and Kondo, Takeshi and Teshima, Takanori},
title = {Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3 ‐ITD positive AML},
journal = {European Journal of Haematology},
year = {2023},
doi = {10.1111/ejh.14055}
}
EUVIMED